MapLight Therapeutics Inc
MPLTLatest QuantConomy context for MPLT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
MapLight Therapeutics Inc
QuantConomy has a structured record for MPLT. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- MPLT
- Name
- MapLight Therapeutics Inc
- Coverage
- 1 market/data records
- Sources
- fmp
Recent signals for MPLT
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| eps change | very bullish | 76 | May 14, 12:00 AM | MPLT (Q1 2026, diluted eps): EPS grew 92.8% ($-18.56 → $-1.34). [sequential period basis, very bullish signal] |
| operating income change | very bullish | 76 | May 14, 12:00 AM | MPLT (Q1 2026, operating income): grew 61.9% (-$169.08M → -$64.50M). [sequential period basis, very bullish signal] |
| net income change | very bullish | 76 | May 14, 12:00 AM | MPLT (Q1 2026, net income): grew 62.4% (-$161.15M → -$60.67M). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| MPLT | NASDAQ | fmp | MapLight Therapeutics, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Babler Martin | Director | grant | 7,864 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Cox Troy | Director | grant | 7,864 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Walker Maria C | Director | grant | 3,932 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Luneborg Nanna Liebach | Director | grant | 3,932 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Pavlov George | Director | grant | 3,932 | $0.00 | $0 | 4 on EDGAR |
| Jun 23, 2026 | Garnett Timothy John | Director | grant | 3,932 | $0.00 | $0 | 4 on EDGAR |
| May 18, 2026 | Kroeger Christopher A. | Chief Executive Officer | sale | 118,037 | $27.19 | $3,209,426 | 4 on EDGAR |
| May 11, 2026 | Hanson Kristopher | General Counsel | sale | 284 | $27.61 | $7,841 | 4 on EDGAR |
| May 7, 2026 | Kroeger Christopher A. | Chief Executive Officer | sale | 14,880 | $28.47 | $423,634 | 4 on EDGAR |
| May 7, 2026 | Foff Erin Pennock | Chief Medical Officer | sale | 4,321 | $28.52 | $123,235 | 4 on EDGAR |
| May 7, 2026 | Lillie James Woodruff | Chief Scientific Officer | sale | 721 | $28.28 | $20,390 | 4 on EDGAR |
| May 4, 2026 | Kroeger Christopher A. | Chief Executive Officer | sale | 9,136 | $27.50 | $251,240 | 4 on EDGAR |
| May 4, 2026 | Setia Vishwas | Chief Financial Officer | sale | 4,803 | $27.36 | $131,410 | 4 on EDGAR |
| May 4, 2026 | Lillie James Woodruff | Chief Scientific Officer | sale | 9,250 | $27.50 | $254,375 | 4 on EDGAR |
| May 4, 2026 | Hanson Kristopher | General Counsel | sale | 9,030 | $27.50 | $248,325 | 4 on EDGAR |
| May 4, 2026 | Foff Erin Pennock | Chief Medical Officer | sale | 9,180 | $27.50 | $252,450 | 4 on EDGAR |
| Apr 27, 2026 | Kreitzer Anatol | Chief Discovery Officer | sale | 8,346 | $28.96 | $241,700 | 4 on EDGAR |
| Apr 27, 2026 | GILLIS JONATHAN | CAAO and PAO | sale | 7,914 | $28.94 | $229,031 | 4 on EDGAR |
| Apr 15, 2026 | Foff Erin Pennock | Chief Medical Officer | sale | 2,044 | $26.84 | $54,861 | 4 on EDGAR |
| Apr 15, 2026 | Hanson Kristopher | General Counsel | sale | 1,529 | $26.80 | $40,977 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query MPLT context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access